HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build
Unknown region code '840'
HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions
Draft as of 2024-08-12 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="nachc-b2-de113"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet nachc-b2-de113</b></p><a name="nachc-b2-de113"> </a><a name="hcnachc-b2-de113"> </a><a name="nachc-b2-de113-en-US"> </a><ul><li>Include these codes as defined in <a href="CodeSystem-hiv-custom.html"><code>http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE113">NACHC.B2.DE113</a></td><td>RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C)</td><td>Hepatitis C Procedures - RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE114">NACHC.B2.DE114</a></td><td>Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C)</td><td>Hepatitis C Procedures - Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE115">NACHC.B2.DE115</a></td><td>Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C)</td><td>Hepatitis C Procedures - Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE116">NACHC.B2.DE116</a></td><td>Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)</td><td>Hepatitis C Procedures - Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE117">NACHC.B2.DE117</a></td><td>Hepatitis C screening documented as performed (HIV)</td><td>Hepatitis C Procedures - Hepatitis C screening documented as performed (HIV)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE118">NACHC.B2.DE118</a></td><td>Patient receiving antiviral treatment for Hepatitis C (HEP-C)</td><td>Hepatitis C Procedures - Patient receiving antiviral treatment for Hepatitis C (HEP-C)</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE119">NACHC.B2.DE119</a></td><td>Collection of venous blood by venipuncture</td><td>Hepatitis C Procedures - Collection of venous blood by venipuncture</td></tr><tr><td><a href="CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE120">NACHC.B2.DE120</a></td><td>Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver</td><td>Hepatitis C Procedures - Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver</td></tr></table></li></ul></div>
</text>
<url value="http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-b2-de113"/>
<version value="0.1.0"/>
<name value="HepatitisCProceduresCodes"/>
<title value="Hepatitis C Procedures Codes"/>
<status value="draft"/>
<experimental value="false"/>
<date value="2024-08-12T19:50:21+00:00"/>
<publisher
value="National Association of Community Health Centers, Inc. (NACHC)"/>
<contact>
<telecom>
<system value="url"/>
<value value="https://www.nachc.org/"/>
</telecom>
</contact>
<description
value="Codes representing possible values for the Hepatitis C Procedures element"/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="840"/>
</coding>
</jurisdiction>
<immutable value="true"/>
<copyright
value="Copyright National Association of Community Health Centers, Inc. (NACHC)"/>
<compose>
<include>
<system
value="http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom"/>
<concept>
<code value="NACHC.B2.DE113"/>
<display
value="RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C)"/>
</concept>
<concept>
<code value="NACHC.B2.DE114"/>
<display
value="Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C)"/>
</concept>
<concept>
<code value="NACHC.B2.DE115"/>
<display
value="Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C)"/>
</concept>
<concept>
<code value="NACHC.B2.DE116"/>
<display
value="Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)"/>
</concept>
<concept>
<code value="NACHC.B2.DE117"/>
<display value="Hepatitis C screening documented as performed (HIV)"/>
</concept>
<concept>
<code value="NACHC.B2.DE118"/>
<display
value="Patient receiving antiviral treatment for Hepatitis C (HEP-C)"/>
</concept>
<concept>
<code value="NACHC.B2.DE119"/>
<display value="Collection of venous blood by venipuncture"/>
</concept>
<concept>
<code value="NACHC.B2.DE120"/>
<display
value="Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver"/>
</concept>
</include>
</compose>
</ValueSet>